DYK? Psychedel*c policy is splitting in two, with FDA medicalization and community decriminalization forging different futures for access to psychedel*cs in the U.S. of A
The FDA track runs through strict clinical frameworks, corporate pharmaceutical patents, and expensive paywalls. The local trac
DYK? Psychedel*c policy is splitting in two, with FDA medicalization and community decriminalization forging different futures for access to psychedel*cs in the U.S. of A The FDA track runs through strict clinical frameworks, corporate pharmaceutical patents, and expensive paywalls. The local trac
0 views
Published on 28/09/2026 16:02
0:30
DYK? Psychedel*c policy is splitting in two, with FDA medicalization and community decriminalization forging different futures for access to psychedel*cs in the U.S. of A
The FDA track runs through strict clinical frameworks, corporate pharmaceutical patents, and expensive paywalls. The local trac
0 comments
?